QALY Weights for Diabetic Retinopathy—A Comparison of Health State Valuations with HUI-3, EQ-5D, EQ-VAS, and TTO
Authors:
- Emelie HeintzEHEmelie Heintz
- Ann-Britt WiréhnAWAnn-Britt Wiréhn
- Beatrice Bourghardt PeeboBPBeatrice Bourghardt Peebo
- Ulf RosenqvistURUlf Rosenqvist
- Lars-Åke LevinLLLars-Åke Levin
- 1 May 2012
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 15 (3) , 475-484
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 DiabetesNew England Journal of Medicine, 2009
- Telephone reliability of the Frenchay Activity Index and EQ-5D amongst older adultsHealth and Quality of Life Outcomes, 2009
- Assessing the empirical validity of alternative multi-attribute utility measures in the maternity contextHealth and Quality of Life Outcomes, 2009
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialThe Lancet, 2008
- The NICE Cost-Effectiveness ThresholdPharmacoEconomics, 2008
- Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaintsQuality of Life Research, 2007
- A comparison of individual and social time trade-off values for health states in the general populationHealth Policy, 2006
- From the Generic to the Condition-specific? Instrument Order Effects in Quality of Life AssessmentMedical Care, 2003
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for HeteroskedasticityEconometrica, 1980